Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line.
Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line.
复制标题
DOI:
10.3892/ol.2013.1494
复制
发表时间:
2013-10
期刊:
影响因子:
2.9
通讯作者:
Harada S
中科院分区:
文献类型:
--
作者:
Hirose A;Tajima H;Ohta T;Tsukada T;Okamoto K;Nakanuma S;Sakai S;Kinoshita J;Makino I;Furukawa H;Hayashi H;Nakamura K;Oyama K;Inokuchi M;Nakagawara H;Miyashita T;Takamura H;Ninomiya I;Kitagawa H;Fushida S;Fujimura T;Harada S
Epidermal-mesenchymal transition (EMT) confers an advantage to cancer cells by improving their invasive capacity and metastatic potential. This phenomenon by which epidermal cells change into mesenchymal cells and therefore acquire a higher ability to automaticity, is considered a key process in cancer development. Transforming growth factor-β (TGF-β) is a significant factor for accelerating EMT through the activation of proteins, including members of the Smad pathway. Furthermore, previous studies have shown that low-dose paclitaxel (PTX) inhibits EMT in certain cell lines, including those of cancer cells. The present study determined whether low-dose PTX was able to inhibit EMT in a human cholangiocarcinoma CCKS-1 cell line that had been treated with TGF-β1. First, the cytotoxic concentration of PTX for the CCKS-1 cells was identified to be ~5 nM by MTT assay and dead cell staining. Therefore, the concentrations of PTX were set as 1 nM, 2.5 nM and 5 nM for the subsequent experiments. In the morphological investigation, the CCKS-1 cells changed into a spindle morphology and became separated by the administration of TGF-β1. However, low-dose PTX inhibited these changes and the morphology resembled the control cells in a dose-dependent manner. Similarly, immunofluorescence and immunoblotting investigations revealed that the CCKS-1 cells expressed mesenchymal markers following the administration of TGF-β1. However, low-dose PTX inhibited the expression of the mesenchymal markers and the CCKS-1 cells expressed the epithelial marker, E-cadherin. In particular, a concentration-dependent effect was observed in the immunoblotting experiments. These results show that PTX may be able to inhibit EMT in cancer cells, depending on the dose concentration.
登录
查看更多内容
影响因子:
7.8
作者:
Greenburg, G;Hay, E D
通讯作者:
Hay, E D
影响因子:
64.8
作者:
SCHIFF, PB;FANT, J;HORWITZ, SB
通讯作者:
HORWITZ, SB
影响因子:
8.4
作者:
ELLIS, PA;NORMAN, A;CUNNINGHAM, D
通讯作者:
CUNNINGHAM, D
影响因子:
16
作者:
Dong, CM;Li, ZR;Goldschmidt-Clermont, PJ
通讯作者:
Goldschmidt-Clermont, PJ
影响因子:
2.7
作者:
Tajima, Hidehiro;Ohta, Tetsuo;Kitamura, Seiko
通讯作者:
Kitamura, Seiko